Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2025 Sep;67(5):e70072.
doi: 10.1002/dev.70072.

Effects of Prenatal DHA Dose on Infant Visual Attention

Affiliations
Clinical Trial

Effects of Prenatal DHA Dose on Infant Visual Attention

John Colombo et al. Dev Psychobiol. 2025 Sep.

Abstract

Prenatal supplementation with docosahexaenoic acid (DHA) has been reported to improve cognitive outcomes in infancy and early childhood in some studies. Existent studies have examined the effects of some dose of DHA against a true placebo; this report is the first to describe the effects of different doses of prenatal DHA on infant visual attention at 4 and 6 months of age. In a follow-up to a Phase III registered clinical trial (NCT02709239) designed to evaluate the effects of two prenatal doses of DHA supplementation (200 or 800 mg daily) on maternal physiology and fetal neurodevelopment, we assessed 215 infants delivered to these mothers at 4 and 6 months on a visual habituation task augmented with heart rate (HR) to assess visual stimulus processing, and a gap-overlap task to assess engagement and disengagement of attention. Infants of mothers supplemented with 800 mg/day of DHA had shorter look durations (indicative of more rapid visual learning) during habituation at both ages and a somewhat more mature pattern of HR-defined phases of attention. However, DHA dose did not affect infant HR, nor did it affect infant performance in the gap-overlap attention task. Results are consistent with positive effects of prenatal DHA supplementation on later outcomes, with higher benefit seen for a higher dose.

Keywords: attention; docosahexaenoic acid; habituation; heart rate; infant; look duration; ocular reaction time; prenatal supplementation.

PubMed Disclaimer

References

    1. Bakker, E. C., A. C. van Houwelingen, and G. Hornstra. 1999. “Early Nutrition, Essential Fatty Acid Status and Visual Acuity of Term Infants at 7 Months of Age.” European Journal of Clinical Nutrition 53, no. 11: 872–879. https://doi.org/10.1038/sj.ejcn.1600868.
    1. Blaga, O. M., and J. Colombo. 2006. “Visual Processing and Infant Ocular Latencies in the Overlap Paradigm.” Developmental Psychology 42, no. 6: 1069–1076. https://doi.org/10.1037/0012‐1649.42.6.1069.
    1. Bornstein, M. H., and J. Colombo. 2012. “Infant Cognitive Functioning and Mental Development.” In Early Childhood Development and Later Outcome. The Jacobs Foundation Series on Adolescence, edited by S. Pauen, 118–147. Cambridge University Press.
    1. Carlson, S. E., and J. Colombo. 2021. “DHA and Cognitive Development.” Journal of Nutrition 151: 3265–3266. https://doi.org/10.1093/jn/nxab299.
    1. Carlson, S. E., J. Colombo, B. J. Gajewski, et al. 2013. “DHA Supplementation and Pregnancy Outcomes.” American Journal of Clinical Nutrition 97, no. 4: 808–815. https://doi.org/10.3945/ajcn.112.050021.

Publication types

Substances